Title: Molecular imaging of prostate cancer
Authors: Emonds, Kimy
Swinnen, Johan
Mortelmans, Luc
Mottaghy, Felix #
Issue Date: Jun-2009
Publisher: Academic press inc elsevier science
Series Title: Methods vol:48 issue:2 pages:193-199
Abstract: Prostate carcinoma is the most common non-cutaneous malignancy in males. Imaging of prostatic lesions is of great importance and aids in oncologic management and monitoring of therapy response. Particularly molecular imaging based on positron emission tomography (PET) and single photon emission computerized tomography (SPECT) has great potential. Using radio-labelled molecular probes, these approaches are highly sensitive and can provide key molecular and functional information on tumours. The identification of suitable targets based on unique genetic and biochemical features of cancer lesions is one of the core activities driving progress in molecular imaging of pathological processes. Nowadays, mainly metabolic probes are being used routinely for detection and staging of prostate cancer. The development of new specific receptor ligands and targeted probes and antibodies holds great promise to further enhance the performance of molecular imaging and to further improve the diagnosis and monitoring of prostate cancer.
ISSN: 1046-2023
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Clinical and Experimental Endocrinology
Nuclear Medicine & Molecular Imaging
Laboratory of Lipid Metabolism and Cancer (+)
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science